BioSpace News Archive

Press Releases

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 13, 2026

March 15, 2026
·
3 min read
Press Releases

Vimgreen’s Novel A2AR Antagonist Receives CDE IND Approval for NASH/MASH Therapy

March 15, 2026
·
5 min read
Press Releases

Contineum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - March 13, 2026

March 15, 2026
·
1 min read
Press Releases

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 13, 2026

March 15, 2026
·
1 min read
Press Releases

Biomea Fusion Presents Phase II COVALENT-111 Data in Type 2 Diabetes at the 19th International Conference on Advanced Technologies & Treatments for Diabetes 2026

March 15, 2026
·
10 min read
Press Releases

Telix Resubmits NDA to U.S. FDA for TLX101-Px (Pixclara®) Brain Cancer Imaging Candidate

March 15, 2026
·
9 min read
Press Releases

First Ever Real-World Evidence of Eversense 365 Presented at ATTD Demonstrates Sustained Performance and Positive Impact Throughout One-Year of Wear

March 15, 2026
·
7 min read
Press Releases

YolTech Therapeutics Receives FDA Clearance to Initiate Phase 2/3 Study of In Vivo Gene-Editing Therapy YOLT-202 in Alpha-1 Antitrypsin Deficiency (AATD)

March 15, 2026
·
2 min read
Press Releases

Samsung Bioepis and Epis NexLab Sign Research Collaboration and License Agreement with G2GBIO to Develop Novel Assets Including Long-acting Semaglutide

March 15, 2026
·
2 min read
Press Releases

GSK’s RSV Vaccine, AREXVY, Approved in US for Expanded Age Indication in Adults Aged 18–49 Years at Increased Risk

March 15, 2026
·
9 min read